Ulcerative colitis: current pharmacotherapy and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ulcerative colitis: current pharmacotherapy and future directions

Published:2014-06-05 Issue:12 Volume:15 Page:1659-1670
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Bezzio Cristina,Furfaro Federica,de Franchis Roberto,Maconi Giovanni,Asthana Anil Kumar,Ardizzone Sandro

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2014.925445

Reference74 articles.

1. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

2. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis

3. Beclomethasone dipropionate (3mg) versus 5-aminosalicylic acid (2g) versus the combination of both (3mg/2g) as retention enemas in active ulcerative proctitis

4. Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials

5. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paeoniflorin improves ulcerative colitis via regulation of PI3K‑AKT based on network pharmacology analysis;Experimental and Therapeutic Medicine;2024-02-05

2. Bletilla striata carbon dots with alleviating effect of DSS-induced ulcerative colitis;Biochemical and Biophysical Research Communications;2024-02

3. Integrated network pharmacology and metabolomics reveal the mechanisms of Jasminum elongatum in anti-ulcerative colitis;Scientific Reports;2023-12-17

4. Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters;Scientific Reports;2023-12-17

5. Exploring the potential of pH-sensitive polymers in targeted drug delivery;Journal of Biomaterials Science, Polymer Edition;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3